Asset Details
Do you wish to reserve the book?
Dual‐Loaded Nanocarriers With High Stability in Gastrointestinal Tract for Type 2 Diabetes and Hypertension Prevention
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Dual‐Loaded Nanocarriers With High Stability in Gastrointestinal Tract for Type 2 Diabetes and Hypertension Prevention
Do you wish to request the book?
Dual‐Loaded Nanocarriers With High Stability in Gastrointestinal Tract for Type 2 Diabetes and Hypertension Prevention
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Dual‐Loaded Nanocarriers With High Stability in Gastrointestinal Tract for Type 2 Diabetes and Hypertension Prevention
2025
Overview
Today, synthetic drugs with side effects on health are used as agents for treating diseases. Moreover, these agents are utilized in the treatment of one specific disease. Consequently, it is essential to develop natural systems that do not harm health and instead foster healing for a range of diseases upon consumption. Therefore, the study focused on examining the behavior of nanocarriers containing the combination of Quercus infectoria gall‐derived phenolic powder (GP) and pomegranate seed‐derived peptide (BP) on type 2 diabetes and hypertension in the in vitro gastrointestinal tract. Firstly, the plausible conditions (enzyme type: Alcalase and enzyme‐to‐protein ratio: 1/20, w/w) for BP production were performed. Nanoliposomal systems having four different natures were called B‐NL (nanoliposome prepared without phyto‐active), GP‐NL (phenolic‐loaded nanoliposome), BP‐NL (peptide‐loaded nanoliposome), and GPBP‐NL (both phenolic and peptide‐loaded nanoliposome). The conversion of protein to peptide resulted in the disappearance of characteristic protein bands in SDS‐PAGE. FTIR spectra indicated that physical interactions predominated within nanocarriers. SEM images showed the dominance of spherical structures for all samples. Particle size (228.90‐364.30 nm), polydispersity index (PDI: 0.10‐0.48), zeta potential (14.50‐17.00 mV), and encapsulation efficiency (EE: 86.33%–90.30%) of nanoliposomes were elaborated. Bioaccessibility of GP (40.05%) and BP (38.09%) was lower than those of their nano‐encased forms (85.92%–87.03%). Also, GP‐NL, BP‐NL, and GPBP‐NL displayed superior inhibition activity toward key enzymes associated with type 2 diabetes and hypertension in the micellar phase compared to their uncoated forms. Ultimately, innovative bifunctional nanocarriers with high potential for treating diabetes and hypertension were developed. Multifunctional nanoliposomes containing phenolics and peptides were designed. Nanoparticles exhibited desirable antidiabetic actions in the micellar phase. Hypertension‐limiting systems were produced for evaluating in vivo applications.
We currently cannot retrieve any items related to this title. Kindly check back at a later time.